Evidence map›Paper›PMID 26114439›Full record

ArticleAmerican journal of respiratory and critical care medicine2015

Phenotype of normal spirometry in an aging population.

Carlos A Vaz Fragoso, Gail McAvay, Peter H Van Ness, Richard Casaburi, Robert L Jensen, Neil MacIntyre, Thomas M Gill, H Klar Yaggi, John Concato

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. GPs should not try to detect mild COPD.NPJ primary care respiratory medicine · 2020
    Article
  8. FEVRespiratory care · 2020
    Article
  9. Article
  10. Association of Breathing Reserve at Peak Exercise With Body Composition and Physical Function in Older Adults With Obesity.The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Article
  11. Physiologic Insights from the COPD Genetic Epidemiology Study.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carlos A Vaz Fragoso1 Veterans Affairs Clinical Epidemiology Research Center, West Haven, Connecticut.
Gail McAvay2 Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Peter H Van Ness2 Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Richard Casaburi3 Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Los Angeles, California.
Robert L Jensen4 LDS Hospital and University of Utah, Salt Lake City, Utah; and.
Neil MacIntyre5 Division of Pulmonary and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina.
Thomas M Gill2 Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
H Klar Yaggi1 Veterans Affairs Clinical Epidemiology Research Center, West Haven, Connecticut.
John Concato1 Veterans Affairs Clinical Epidemiology Research Center, West Haven, Connecticut.

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Metabolomic signatures of empysema and COPD progression in the COPDGene cohortR01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2012 to 2016
$31.1M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
ACADEMIC LEADERSHIP AWARD IN DISABILITY AND DISABLING DISORDERSK07AG043587 · NIA · YALE UNIVERSITY · PI GILL, THOMAS MICHAEL · 2013 to 2017
$645k
Respiratory Impairment in Aging PopulationsI01CX000927 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI FRAGOSO, CARLOS A. VAZ · 2014 to 2016
–
NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01HL089856NHLBI NIH HHS R01 HL089897NHLBI NIH HHS R01HL089897NIA NIH HHS K07 AG043587NIA NIH HHS K07AG043587
6 · The paper itself

Abstract

rationaleIn aging populations, the commonly used Global Initiative for Chronic Obstructive Lung Disease (GOLD) may misclassify normal spirometry as respiratory impairment (airflow obstruction and restrictive pattern), including the presumption of respiratory disease (chronic obstructive pulmonary disease [COPD]).

objectivesTo evaluate the phenotype of normal spirometry as defined by a new approach from the Global Lung Initiative (GLI), overall and across GOLD spirometric categories.

methodsUsing data from COPDGene (n = 10,131; ages 45-81; smoking history, ≥10 pack-years), we evaluated spirometry and multiple phenotypes, including dyspnea severity (Modified Medical Research Council grade 0-4), health-related quality of life (St. George's Respiratory Questionnaire total score), 6-minute-walk distance, bronchodilator reversibility (FEV1 % change), computed tomography-measured percentage of lung with emphysema (% emphysema) and gas trapping (% gas trapping), and small airway dimensions (square root of the wall area for a standardized airway with an internal perimeter of 10 mm). MEASUREMENTS AND MAIN

resultsAmong 5,100 participants with GLI-defined normal spirometry, GOLD identified respiratory impairment in 1,146 (22.5%), including a restrictive pattern in 464 (9.1%), mild COPD in 380 (7.5%), moderate COPD in 302 (5.9%), and severe COPD in none. Overall, the phenotype of GLI-defined normal spirometry included normal adjusted mean values for dyspnea grade (0.8), St. George's Respiratory Questionnaire (15.9), 6-minute-walk distance (1,424 ft [434 m]), bronchodilator reversibility (2.7%), % emphysema (0.9%), % gas trapping (10.7%), and square root of the wall area for a standardized airway with an internal perimeter of 10 mm (3.65 mm); corresponding 95% confidence intervals were similarly normal. These phenotypes remained normal for GLI-defined normal spirometry across GOLD spirometric categories.

conclusionsGLI-defined normal spirometry, even when classified as respiratory impairment by GOLD, included adjusted mean values in the normal range for multiple phenotypes. These results suggest that among adults with GLI-defined normal spirometry, GOLD may misclassify normal phenotypes as having respiratory impairment.

Indexed as

PhenotypeSpirometryAgedAged, 80 and overAirway ObstructionDiagnostic ErrorsFemaleHumansMaleMiddle AgedModels, StatisticalPulmonary Disease, Chronic ObstructivePulmonary EmphysemaQuality of LifeCOPDCOPDGeneemphysemanormal spirometryphenotype

Identifiers

PMID26114439
PMCPMC4613896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.